Construction of polyethylene glycol-cloaked mesoporous polydopamine nanomaterials co-loaded with anticancer drugs for photo/chemotherapy of lung cancer cells and elucidation of the cell death mechanism.
- 1Department of the Laboratory, Anting Hospital, Jiading District, Shanghai, 201805, China.
- 2Department of Science and Education, Anting Hospital, Jiading District, Shanghai, 201805, China. [email protected].
Abstract
Lung cancer is one of the leading causes of cancer-related deaths worldwide. The mortality rate can be reduced through the development of novel therapeutic drugs for lung cancer. In this study, we developed nanoparticles (NPs) consisting of polyethylene glycol (PEG)-cloaked mesoporous polydopamine (MP) loaded with indocyanine green (IG) and talazoparib (TZ), designed to combine therapies for lung cancer. MP NPs were synthesized and surface-capped with methoxypolyethylene glycol amine. PEG2K-MP and PEG5K-MP NPs were analyzed using dynamic light scattering, scanning electron microscopy, and transmission electron microscopy. PEG2K-MP@IG&TZ and PEG5K-MP@IG&TZ NPs were developed using the solvent diffusion technique to co-load IG and TZ. The reduction in drug-feeding ratios led to a decrease in the amount of drug loaded and an increase in the encapsulation efficiency. PEG2K-MP@IG&TZ and PEG5K-MP@IG&TZ NPs, which showed excellent drug loading efficiency (IG: 9.9 ± 0.4% and 9.1 ± 0.2%; TZ: 6.8 ± 0.3% and 6.5 ± 0.2%), were chosen for further investigation. The hydrodynamic sizes ranged from 200 to 300 nm. These nanoparticles exhibited improved stability of IG in water, near-infrared laser-stimulated release of TZ, effective photothermal activity, excellent biocompatibility, and increased cellular uptake. These two nanoparticles demonstrated a stronger anticancer effect on lung cancer A549 cells than the combination of IG and TZ when irradiated with 808 nm light in vitro. Fluorescence microscopy revealed that PEG5K-MP@IG&TZ NPs efficiently triggered apoptosis in A549 cells. This study presents an innovative and efficient method for combination therapy against lung cancer cells.
Related
- Nanofibers of polyester–polydopamine copolymers enable combined photothermal effect and chemotherapy for local cancer treatment
- Construction of a risk prediction model for chemotherapy-induced taste alteration in patients with hematological malignancies
- CHBP-loaded mesoporous polydopamine nanoparticles attenuate neuroinflammation and reprogram microglia-neuron crosstalk for spinal cord injury repair
- Fe-doped polydopamine pickering emulsion as a nanoplatform for synergistic photothermal-ferroptosis immunotherapy in breast cancer
- Polydopamine-mediated curcumin-functionalized electroactive nanofibrous scaffold accelerates infected wound healing via multifactorial microenvironment remodeling.
BibTeX
@article{hu2026construction,
title = {{Construction of polyethylene glycol-cloaked mesoporous polydopamine nanomaterials co-loaded with anticancer drugs for photo/chemotherapy of lung cancer cells and elucidation of the cell death mechanism.}},
author = {Yueming Hu and Xiaolei Han},
journal = {Journal of materials science. Materials in medicine},
year = {2026},
month = jul,
doi = {10.1007/s10856-026-07106-2},
url = {https://europepmc.org/article/MED/42902007},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Construction of polyethylene glycol-cloaked mesoporous polydopamine nanomaterials co-loaded with anticancer drugs for photo/chemotherapy of lung cancer cells and elucidation of the cell death mechanism.
AU - Yueming Hu
AU - Xiaolei Han
PY - 2026
DA - 2026/07/01
JO - Journal of materials science. Materials in medicine
DO - 10.1007/s10856-026-07106-2
UR - https://europepmc.org/article/MED/42902007
AB - Lung cancer is one of the leading causes of cancer-related deaths worldwide. The mortality rate can be reduced through the development of novel therapeutic drugs for lung cancer. In this study, we developed nanoparticles (NPs) consisting of polyethylene glycol (PEG)-cloaked mesoporous polydopamine (MP) loaded with indocyanine green (IG) and talazoparib (TZ), designed to combine therapies for lung cancer. MP NPs were synthesized and surface-capped with methoxypolyethylene glycol amine. PEG2K-MP and PEG5K-MP NPs were analyzed using dynamic light scattering, scanning electron microscopy, and transmission electron microscopy. PEG2K-MP@IG&TZ and PEG5K-MP@IG&TZ NPs were developed using the solvent diffusion technique to co-load IG and TZ. The reduction in drug-feeding ratios led to a decrease in the amount of drug loaded and an increase in the encapsulation efficiency. PEG2K-MP@IG&TZ and PEG5K-MP@IG&TZ NPs, which showed excellent drug loading efficiency (IG: 9.9 ± 0.4% and 9.1 ± 0.2%; TZ: 6.8 ± 0.3% and 6.5 ± 0.2%), were chosen for further investigation. The hydrodynamic sizes ranged from 200 to 300 nm. These nanoparticles exhibited improved stability of IG in water, near-infrared laser-stimulated release of TZ, effective photothermal activity, excellent biocompatibility, and increased cellular uptake. These two nanoparticles demonstrated a stronger anticancer effect on lung cancer A549 cells than the combination of IG and TZ when irradiated with 808 nm light in vitro. Fluorescence microscopy revealed that PEG5K-MP@IG&TZ NPs efficiently triggered apoptosis in A549 cells. This study presents an innovative and efficient method for combination therapy against lung cancer cells.
SN - 0957-4530
SN - 1573-4838
ER -